Register entry
- Registered sites
- 0
- Active NDC listings
- 6
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
66 active NDC listings: 6 human otc drug. By marketing category: OTC MONOGRAPH DRUG 6.
| Dosage form | NDCs |
|---|---|
| cream | 4 |
| liquid | 1 |
| lotion | 1 |
| Route | NDCs |
|---|---|
| topical | 6 |
| Labeller name on the listing | NDCs |
|---|---|
| neostrata company inc. | 6 |
Catalogue
Marketed products
6| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Exuviance Age Reverse Day Repair with Sunscreen Broad Spectrum SPF 30 | avobenzone, octinoxate, and octisalate | cream, topical | 58414-0023OTC MONOGRAPH DRUG |
| Exuviance Daily Acne Peel | SALICYLIC ACID | liquid, topical | 58414-0017OTC MONOGRAPH DRUG |
| Exuviance Daily Corrector with Sunsreen Broad Spectrum SPF 35 | Octinoxate, Octisalate, and Avobenzone | cream, topical | 58414-0024OTC MONOGRAPH DRUG |
| NeoStrata Enlighten Skin Brightener with Sunscreen Broad Spectrum SPF 35 | Octinoxate, Octisalate, and Avobenzone | cream, topical | 58414-0019OTC MONOGRAPH DRUG |
| NeoStrata Sheer Hydration Sunscreen Broad Spectrum SPF 40 | Octinoxate, Octisalate, and Avobenzone | lotion, topical | 58414-0020OTC MONOGRAPH DRUG |
| NeoStrata Skin Active Matrix Support SPF 30 | AVOBENZONE, OCTINOXATE, and OCTISALATE | cream, topical | 58414-3042OTC MONOGRAPH DRUG |
Enquiry
Common questions
- Is NeoStrata Company Inc. FDA approved?
- NeoStrata Company Inc. holds no registered establishment of its own; 6 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does NeoStrata Company Inc. make?
- 6 products are listed under NeoStrata Company Inc. in the openFDA NDC Directory, most often as cream; liquid; lotion. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.